DiaMedica Therapeutics, Inc. (DMAC) International Stroke Conference 2022 Posters https://www.diamedica.com/international-stroke-conference-2022-posters/rss en-us https://d1io3yog0oux5.cloudfront.net/diamedica/files/theme/images/logo-sm.png DiaMedica Therapeutics, Inc. Logo https://www.diamedica.com Equisolve Investor Relations Suite <![CDATA[Stroke Recurrence And Mortality With Recombinant Tissue Kallikrein Protein In The Remedy1 Phase 2 Trial]]> https://d1io3yog0oux5.cloudfront.net/_7d63216d5df9f33c54c3bee145d506f5/diamedica/db/291/2983/pdf/22-1045-B+ISC+-+Recurrence_v2.pdf Sun, 05 Apr 26 03:31:56 -0400 https://d1io3yog0oux5.cloudfront.net/_7d63216d5df9f33c54c3bee145d506f5/diamedica/db/291/2983/pdf/22-1045-B+ISC+-+Recurrence_v2.pdf <![CDATA[Randomized, Double-blind, Placebo-controlled, Adaptive Design Study To Evaluate Dm199 For The Treatment Of Acute Ischemic Stroke (ReMEDy2 Trial)]]> https://d1io3yog0oux5.cloudfront.net/_7d63216d5df9f33c54c3bee145d506f5/diamedica/db/291/2982/pdf/22-1045-A+ISC+-+REMEDY+2_v6.pdf Sun, 05 Apr 26 03:31:56 -0400 https://d1io3yog0oux5.cloudfront.net/_7d63216d5df9f33c54c3bee145d506f5/diamedica/db/291/2982/pdf/22-1045-A+ISC+-+REMEDY+2_v6.pdf